Noxopharm Limited logo

Noxopharm Limited

ASX:NOX.AX

Overview | Financials
Company Name Noxopharm Limited
Symbol NOX.AX
Currency AUD
Price 0.072
Market Cap 21,041,136
Dividend Yield 0%
52-week-range 0.033 - 0.165
Industry Biotechnology
Sector Healthcare
CEO Dr. Gisela Mautner
Website https://www.noxopharm.com

An error occurred while fetching data.

About Noxopharm Limited

Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program

Related Stocks

Antisense Therapeutics Limited logo

Antisense Therapeutics Limited

ANP.AX

0.058 AUD

Microba Life Sciences Limited logo

Microba Life Sciences Limited

MAP.AX

0.165 AUD

Orthocell Limited logo

Orthocell Limited

OCC.AX

0.39 AUD

Emyria Limited logo

Emyria Limited

EMD.AX

0.046 AUD

Cynata Therapeutics Limited logo

Cynata Therapeutics Limited

CYP.AX

0.26 AUD

MedAdvisor Limited logo

MedAdvisor Limited

MDR.AX

0.54 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD